Mar 42022

Newly Proposed SEC Cybersecurity Risk Management Rules and Amendments for Registered Investment Advisers and Funds

Jay G. Baris, Nathan J. Greene, Colleen Theresa Brown, Sujit Raman and Sasha Hondagneu-Messner
, , ,
On February 9, 2022, the U.S. Securities and Exchange Commission (SEC) proposed comprehensive rules for registered advisers and funds. Among other things, these rules will require advisers and funds to implement written policies and procedures designed to address cybersecurity risks, report significant cybersecurity incidents to the SEC within 48 hours using a proposed form, and keep enumerated cybersecurity-related books and records. Initial reactions have been mixed, including a published dissent from Commissioner Hester Peirce. A public comment period is ongoing.

Read more.

This post is as of the posting date stated above. Sidley Austin LLP assumes no duty to update this post or post about any subsequent developments having a bearing on this post.

Jay G. Baris

New York

jbaris@sidley.com

Nathan J. Greene

New York

ngreene@sidley.com

Colleen Theresa Brown

Washington, D.C.

cbrown@sidley.com

Sujit Raman

sraman@sidley.com

Sasha Hondagneu-Messner

New York

shondagneumessner@sidley.com

You might also like
Schumer Framework May Forge U.S. Model on AI Governance

*This article first appeared on Law360 on September 5, 2023.

This summer, Senate Majority Leader Chuck Schumer proposed a distinctive new framework to develop a comprehensive artificial intelligence regulatory policy that is intended to be adamantly bipartisan and committed, as a first principle, to preserving innovation and intellectual property rights.

Regulatory Update: National Association of Insurance Commissioners Summer 2023 National Meeting

The National Association of Insurance Commissioners (NAIC) held its Summer 2023 National Meeting (Summer Meeting) from August 12–16, 2023. Highlights include continued development of accounting principles and investment limitations related to certain types of bonds and structured securities, continued discussion of considerations related to private equity ownership of insurers, a proposed model bulletin addressing the use of artificial intelligence by the insurance industry, and continued development of a new consumer privacy protections model law.

EU, U.S., and UK Regulatory Developments on the Use of Artificial Intelligence in the Drug Lifecycle

Globally, the rapid advancement of artificial intelligence (AI) and machine learning (ML) raises fundamental questions about how the technology can be used. Drug approval authorities are now also taking part in this discussion, resulting in emerging and evolving guidelines and principles for drug companies.